These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16997042)

  • 1. Federal Drug Administration authority and the emergency nurse: implications for patient safety.
    Hackenschmidt A
    J Emerg Nurs; 2006 Oct; 32(5):449-50. PubMed ID: 16997042
    [No Abstract]   [Full Text] [Related]  

  • 2. A primer of drug safety surveillance: an industry perspective. Part I: Information flow, new drug development, and federal regulations.
    Allan MC
    J Pharm Technol; 1992; 8(4):162-7. PubMed ID: 10121011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reform of drug regulation--beyond an independent drug-safety board.
    Ray WA; Stein CM
    N Engl J Med; 2006 Jan; 354(2):194-201. PubMed ID: 16407517
    [No Abstract]   [Full Text] [Related]  

  • 4. How can you promote vaccine safety?
    Miller ER; Iskander J; Pickering S; Varricchio F
    Nursing; 2007 Apr; 37(4):58-63; quiz 63-4. PubMed ID: 17413371
    [No Abstract]   [Full Text] [Related]  

  • 5. How are drugs approved? Part 1: the evolution of the Food and Drug Administration.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Jan; 46(1):15-9. PubMed ID: 18251347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices: promoting a safe migration into the home.
    Weick-Brady MD; Lazerow RN
    Home Healthc Nurse; 2006 May; 24(5):298-304; quiz 305-6. PubMed ID: 16699341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M
    N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract]   [Full Text] [Related]  

  • 8. Protecting the health of the public--Institute of Medicine recommendations on drug safety.
    Psaty BM; Burke SP
    N Engl J Med; 2006 Oct; 355(17):1753-5. PubMed ID: 17030843
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug safety. Gaps in the safety net.
    Couzin J
    Science; 2005 Jan; 307(5707):196-8. PubMed ID: 15653480
    [No Abstract]   [Full Text] [Related]  

  • 10. [The nurse and public health surveillance].
    Chevillotte J; Venchiarutti L
    Rev Infirm; 2008 Sep; (143):29-31. PubMed ID: 18788665
    [No Abstract]   [Full Text] [Related]  

  • 11. The drive to reform the FDA gains momentum.
    Gatty B
    Hosp Formul; 1995 Mar; 30(3):178, 177. PubMed ID: 10141250
    [No Abstract]   [Full Text] [Related]  

  • 12. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL; Hanson A; Guglielmetti TM; Levy K
    Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
    [No Abstract]   [Full Text] [Related]  

  • 13. How pharmaceuticals are developed.
    Vander Elst E
    J Am Dent Assoc; 1994 Jan; 125 Suppl():40S-44S. PubMed ID: 8294674
    [No Abstract]   [Full Text] [Related]  

  • 14. Automated medication dispensing systems: not error free.
    Paparella S
    J Emerg Nurs; 2006 Feb; 32(1):71-4. PubMed ID: 16439294
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety surveillance in drug development: understanding the process and its implications for nephrology nursing.
    Browar S
    Nephrol Nurs J; 2002 Apr; 29(2):143-50. PubMed ID: 11997949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How are drugs approved? Part 2: ethical foundations of clinical research.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Feb; 46(2):15-20. PubMed ID: 18293779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety in numbers--monitoring risk in approved drugs.
    Okie S
    N Engl J Med; 2005 Mar; 352(12):1173-6. PubMed ID: 15788493
    [No Abstract]   [Full Text] [Related]  

  • 18. U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
    Goldman SA
    Food Drug Law J; 2007; 62(3):513-28. PubMed ID: 17915393
    [No Abstract]   [Full Text] [Related]  

  • 19. What ails the FDA?
    Okie S
    N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.